Ngā hua rapu - Chava Perry

CREB Regulates AChE-R-Induced Proliferation of Human Glioblastoma Cells mā Chava Perry, Ella H. Sklan, Hermona Soreq

Whiwhi kuputuhi katoa

Spontaneous Metabolic Regression in High-Burden Follicular Lymphoma: A Case Report mā Yotam Bronstein, Roy Vitkon, Lucille Hayman, Chava Perry

Whiwhi kuputuhi katoa

PB2288: INCIDENCE OF NEWLY DIAGNOSED AGGRESSIVE NON-HODGKIN’S LYMPHOMA BEFORE AND DURING THE COVID-19 PANDEMIC IN ISRAEL - A SINGLE CENTER RETROSPECTIVE STUDY mā Yotam Bronstein, Eugene Feigin, Irit Avivi, Erel Joffe, Chava Perry

Whiwhi kuputuhi katoa

SLP76 integrates into the B-cell receptor signaling cascade in chronic lymphocytic leukemia cells and is associated with an aggressive disease course mā Nili Dezorella, Ben-Zion Katz, Mika Shapiro, Aaron Polliack, Chava Perry, Yair Herishanu

Whiwhi kuputuhi katoa

REGEN‐COV antibody combination in patients with lymphoproliferative malignancies and SARS‐CoV‐2 infection mā Yotam Bronstein, Irit Avivi, Yael C Cohen, Eugene Feigin, Chava Perry, Yair Herishanu

Whiwhi kuputuhi katoa

Attenuated antibody responses to respiratory syncytial virus vaccination in hematologic malignancies: impact of anti-CD20 therapy mā Yair Herishanu, Yotam Bronstein, Ora Halutz, Dana Gamzu, Chava Perry, Yael Cohen, Irit Avivi

Whiwhi kuputuhi katoa

Proteolysis Targeting Chimeras for BTK Efficiently Inhibit B-Cell Receptor Signaling and Can Overcome Ibrutinib Resistance in CLL Cells mā Yamit Shorer Arbel, Ben-Zion Katz, Ben-Zion Katz, Ronen Gabizon, Amit Shraga, Yotam Bronstein, Talia Kamdjou, Anat Globerson Levin, Chava Perry, Chava Perry, Irit Avivi, Irit Avivi, Nir London, Yair Herishanu, Yair Herishanu

Whiwhi kuputuhi katoa

Endurance exercise diverts the balance between Th17 cells and regulatory T cells. mā Chava Perry, Marjorie Pick, Nir Bdolach, Inbal Hazan-Halevi, Sigi Kay, Idit Berr, Adi Reches, Yair Harishanu, Dan Grisaru

Whiwhi kuputuhi katoa

Flow Cytometry-based Detection of B-cell Lymphoproliferative Disorders in Patients with Mycosis Fungoides mā Shamir Geller, Sigi Kay, Eran Ellenbogen, Tomer Goldsmith, Shoshi Bar-On, Emily Warshauer, Varda Deutsch, Eli Sprecher, Chava Perry, Ilan Goldberg

Whiwhi kuputuhi katoa

Lymphocyte activation gene 3: a novel therapeutic target in chronic lymphocytic leukemia mā Mika Shapiro, Yair Herishanu, Ben-Zion Katz, Nili Dezorella, Clare Sun, Sigi Kay, Aaron Polliack, Irit Avivi, Adrian Wiestner, Chava Perry

Whiwhi kuputuhi katoa

Anti-CD20-Mediated B Cell Depletion Is Associated With Bone Preservation in Lymphoma Patients and Bone Mass Increase in Mice mā Albert Kolomansky, Albert Kolomansky, Albert Kolomansky, Irit Kaye, Irit Kaye, Nathalie Ben-Califa, Nathalie Ben-Califa, Anton Gorodov, Anton Gorodov, Anton Gorodov, Zamzam Awida, Zamzam Awida, Ofer Sadovnic, Ofer Sadovnic, Maria Ibrahim, Maria Ibrahim, Tamar Liron, Tamar Liron, Sahar Hiram-Bab, Sahar Hiram-Bab, Howard S. Oster, Howard S. Oster, Nadav Sarid, Nadav Sarid, Chava Perry, Chava Perry, Yankel Gabet, Yankel Gabet, Moshe Mittelman, Moshe Mittelman, Drorit Neumann, Drorit Neumann

Whiwhi kuputuhi katoa

ICANS mitigation in high-risk elderly patients treated with CD28 co-stimulatory anti-CD19 CAR-T cells using a standardization protocol: a pilot study mā Gil Fridberg, Odelia Amit, Yehonathan Sherf, Chava Perry, Yair Herishanu, Erel Joffe, Tamir Shragai, Roy Vitkon, Meir Preis, Shoshan Perk, Nadav Sarid, Sharon Ben Barouch, Ronit Gold, Chen Glait-Santar, Irit Avivi, Ron Ram

Whiwhi kuputuhi katoa

Toxicity and efficacy of chimeric antigen receptor T-cell therapy in patients with diffuse large B-cell lymphoma above the age of 70 years compared to younger patients – a matched... mā Ron Ram, Sigal Grisariu, Liat Shargian-Alon, Odelia Amit, Yaeli Bar-On, Polina Stepensky, Moshe Yeshurun, Batia Avni, David Hagin, Chava Perry, Ronit Gurion, Nadav Sarid, Yair Herishanu, Ronit Gold, Chen Glait-Santar, Sigi Kay, Irit Avivi

Whiwhi kuputuhi katoa